Skip to main content

Table 1 Demographic data, histologic, basic clinical data, and treatments of the 120 patients at the time of diagnosis of loco-regionally advanced gastric cancer. Percentages in the total column refer to the total number of patients included (n = 120)

From: Prognostic factors in patients with loco-regionally advanced gastric cancer

Variables

2000–2004

2005–2009

Total

Number of patients included

73

47

120 (100%)

Median age in years (range)

71 (26–91)

68 (41–90)

70.5 (26–91)

Gender

 Female

34

21

55 (46%)

 Male

39

26

65 (54%)

Karnofsky performance status

 100

32

20

52 (43%)

 90

13

13

26 (22%)

 10–80

28

14

42 (35%)

Loco-regionally advanced cancer

 Synchronous

47

33

80 (67%)

 Metachronous

26

14

40 (33%)

Morphological type

 Signet ring cells (SRS)

18

19

37 (31%)

 Adenocarcinoma without SRS

48

27

75 (63%)

 Linitis plastica

1

0

1 (1%)

 Missing data

6

1

7 (6%)

Differentiation

 Poorly differentiated

48

36

84 (70%)

 Moderately differentiated

13

4

17 (14%)

 Well-differentiated

1

1

2 (2%)

 Missing data

11

6

17 (12%)

Lauren’s classification

 Intestinal type

17

14

31 (26%)

 Gastric type

1

1

2 (2%)

 Diffuse type

22

12

34 (28%)

 Mixed type

0

2

2 (2%)

 Missing data

33

18

51 (43%)

Distant metastasis

 No

45

26

71 (59%)

 Yes

28

21

49 (41%)

  Synchronous

18

16

34 (28%)

  Metachronous

10

5

15 (12%)

Palliative treatment

 Chemotherapy

33

20

53 (44%)

 Radiotherapy

0

2

2 (2%)

 Chemoradiotherapy

5

2

7 (6%)